Altimmune, Inc. — Investor Relations & Filings
Filings indexed
1,027
across all filing types
Latest filing
2026-05-13
Regulatory Filings
Country
US
United States of America
Listing
US
ALT
Altimmune, Inc. is a clinical-stage biopharmaceutical company focused on developing novel peptide-based therapeutics. The company's primary areas of development are treatments for obesity and liver diseases, including metabolic dysfunction-associated steatohepatitis (MASH). Its lead product candidate is pemvidutide. Altimmune also develops immune-modulating therapies for a range of diseases.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| S-8 - Altimmune, Inc. (0001326190) (Filer) | 2026-05-13 | English | |
| 8-K - Altimmune, Inc. (0001326190) (Filer) | 2026-05-13 | English | |
| 424B5 - Altimmune, Inc. (0001326190) (Filer) | 2026-04-22 | English | |
| 8-K - Altimmune, Inc. (0001326190) (Filer) | 2026-04-16 | English | |
| SCHEDULE 13G/A - Altimmune, Inc. (0001326190) (Subject) | 2026-03-26 | English | |
| ARS - Altimmune, Inc. (0001326190) (Filer) | 2026-03-17 | English |
Browse filings by year
17 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 45762225 | S-8 - Altimmune, Inc. (0001326190) (Filer) | 2026-05-13 | English | ||
| 45566430 | 8-K - Altimmune, Inc. (0001326190) (Filer) | 2026-05-13 | English | ||
| 35420887 | 424B5 - Altimmune, Inc. (0001326190) (Filer) | 2026-04-22 | English | ||
| 34650374 | 8-K - Altimmune, Inc. (0001326190) (Filer) | 2026-04-16 | English | ||
| 33051711 | SCHEDULE 13G/A - Altimmune, Inc. (0001326190) (Subject) | 2026-03-26 | English | ||
| 32963698 | ARS - Altimmune, Inc. (0001326190) (Filer) | 2026-03-17 | English | ||
| 32963520 | DEF 14A - Altimmune, Inc. (0001326190) (Filer) | 2026-03-17 | English | ||
| 32890153 | 4 - ALTIMMUNE, INC. (0001326190) (Filer) | 2026-02-27 | English | ||
| 32890154 | 4 - ALTIMMUNE, INC. (0001326190) (Filer) | 2026-02-27 | English | ||
| 28892416 | S-8 Filing | 2026-02-06 | English | ||
| 28892707 | 4 Filing | 2026-02-03 | English | ||
| 28892674 | 8-K Filing | 2026-02-03 | English | ||
| 28892751 | 4 Filing | 2026-02-02 | English | ||
| 28892488 | 4 Filing | 2026-02-02 | English | ||
| 28892466 | SCHEDULE 13G/A Filing | 2026-01-30 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Antibiotice S.A.
Pharmaceutical firm manufacturing generic medicines, anti-i…
|
ATB | RO | Manufacturing |
|
Anuh Pharma Ltd.
Manufacturer of APIs and bulk drugs specializing in Macroli…
|
ANUHPHR | IN | Manufacturing |
|
Apellis Pharmaceuticals, Inc.
Biopharmaceutical company developing therapies by targeting…
|
APLS | US | Manufacturing |
|
Apeloa Pharmaceutical Co.,Ltd.
Integrated provider of APIs, CDMO services, and finished dr…
|
000739 | CN | Manufacturing |
|
APEX HEALTHCARE BERHAD
Integrated pharmaceutical group manufacturing and distribut…
|
— | MY | Manufacturing |
|
ApicHope Pharmaceutical Group Co.,Ltd
Pharmaceutical firm focused on pediatric, chronic, and card…
|
300723 | CN | Manufacturing |
|
Apimeds Pharmaceuticals US, Inc.
Clinical-stage biopharma developing a bee venom drug and AI…
|
APUS | US | Manufacturing |
|
Apogee Therapeutics, Inc.
Clinical-stage biotech developing biologics for immunologic…
|
APGE | US | Manufacturing |
|
Apollomics Inc.
Clinical-stage biotech developing innovative oncology and c…
|
APLM | US | Manufacturing |
|
Apontis Pharma AG
Develops and markets fixed-dose combination drugs (Single P…
|
APPH | DE | Manufacturing |
Altimmune, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/33207/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=33207 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=33207 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=33207 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 33207}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Altimmune, Inc. (id: 33207)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.